FDA Inspection 636223 — CorePharma, LLC

CorePharma, LLC — FEI 3002535019

The FDA completed an inspection of CorePharma, LLC on Jan 20, 2010 in Middlesex, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Jan 20, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Middlesex, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.